Net Income (Loss) Attributable to Parent in USD of VACCINEX, INC. from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
VACCINEX, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2017 to Q4 2024.
  • VACCINEX, INC. Net Income (Loss) Attributable to Parent for the quarter ending 31 Dec 2024 was -$3,374,000.000, a 1.72% decline year-over-year.
  • VACCINEX, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 31 Dec 2024 was -$18,634,000.000, a 7.99% increase year-over-year.
  • VACCINEX, INC. annual Net Income (Loss) Attributable to Parent for 2024 was -$18,634,000.000, a 7.99% increase from 2023.
  • VACCINEX, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$20,251,000.000, a 2.2% decline from 2022.
  • VACCINEX, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$19,815,000.000, a 11.5% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

VACCINEX, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$18,634,000 -$3,374,000 -$57,000 -1.7% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$18,577,000 -$5,732,000 -$820,000 -16.7% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 -$17,757,000 -$5,631,000 +$1,429,000 +20.2% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 -$19,186,000 -$3,897,000 +$1,065,000 +21.5% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$20,251,000 -$3,317,000 +$1,761,000 +34.7% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$22,012,000 -$4,912,000 -$153,000 -3.2% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$21,859,000 -$7,060,000 -$1,677,000 -31.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$20,182,000 -$4,962,000 -$367,000 -8% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$19,815,000 -$5,078,000 -$447,000 -9.7% 01 Oct 2022 31 Dec 2022 10-K/A 25 Apr 2024
Q3 2022 -$19,368,000 -$4,759,000 +$447,000 +8.6% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$19,815,000 -$5,383,000 +$586,000 +9.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$20,401,000 -$4,595,000 +$1,979,000 +30.1% 01 Jan 2022 31 Mar 2022 10-Q 16 May 2022
Q4 2021 -$22,380,000 -$4,631,000 +$1,816,000 +28.2% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2022
Q3 2021 -$24,196,000 -$5,206,000 +$3,548,000 +40.5% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$27,744,000 -$5,969,000 +$532,000 +8.2% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 -$28,276,000 -$6,574,000 +$575,000 +8% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 -$28,851,000 -$6,447,000 -$121,000 -1.9% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$28,730,000 -$8,754,000 -$1,112,000 -14.6% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$27,618,000 -$6,501,000 +$2,327,000 +26.4% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$29,945,000 -$7,149,000 +$1,918,000 +21.2% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 -$31,863,000 -$6,326,000 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$7,642,000 -$1,043,000 -15.8% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 -$8,828,000 -$2,220,000 -33.6% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 -$9,067,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q3 2018 -$6,599,000 -$1,063,000 -19.2% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$6,608,000 -$1,729,000 -35.4% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q3 2017 -$5,536,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 -$4,879,000 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018

VACCINEX, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$18,634,000 +$1,617,000 +8% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$20,251,000 -$436,000 -2.2% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 -$19,815,000 +$2,565,000 +11.5% 01 Jan 2022 31 Dec 2022 10-K/A 25 Apr 2024
2021 -$22,380,000 +$6,471,000 +22.4% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2022
2020 -$28,851,000 +$3,012,000 +9.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$31,863,000 -$2,345,000 -7.9% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$29,518,000 -$10,796,000 -57.7% 01 Jan 2018 31 Dec 2018 10-K 09 Mar 2020
2017 -$18,722,000 01 Jan 2017 31 Dec 2017 10-K 13 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.